innoscripta SE, a provider of the Clusterix software platform for managing research and development (R&D) activities, announced its financial results for the first half of 2026, showing robust growth driven by the German R&D tax allowance and strategic international expansion. The company reported a 43% increase in revenue to EUR 63.1 million compared to the same period in 2025. Adjusted EBIT, excluding EUR 535 thousand in non-recurring expenses related to corporate restructuring, rose by 49% to EUR 36.4 million, yielding an adjusted EBIT margin of 57.7%.
The German R&D tax allowance (Forschungszulage) remains a key growth driver, with the number of innoscripta customers exceeding 2,900 during the first half. The company continued to enhance Clusterix as its central infrastructure for project structuring, data management, and application submissions. This upgrade enables automated data validation, higher data quality, and faster, more standardized processes, establishing consistent workflows across different markets and providing a technological foundation for further international scaling.
International expansion progressed as planned, with successful market entries into France, the UK, and the US. In France, innoscripta opened its first location near Toulouse and has already secured customers. The company entered the UK market with a Manchester office in July 2026 and is now active in the US, serving its first companies in this high-growth market. Clusterix's flexibility in adapting to different regulatory requirements allows efficient entry into new markets.
"The first half of 2026 demonstrates the strength of our business model and the scalability of Clusterix," said Max Hunger, CEO of innoscripta. "Our international expansion is on track, and we are confident in confirming our full-year guidance."
The Management Board confirms its guidance for the current financial year, expecting Group revenue of at least EUR 140 million and EBIT of at least EUR 80 million, assuming consistent timing of submission and approval of customers' applications.
Detailed financial figures are available in the Half-Year Report on the company's website in the Investors section. Additionally, innoscripta will host a virtual earnings call on its H1 2026 results today at 3:00 p.m. CEST, with dial-in details available under Investor Events.
innoscripta SE offers Clusterix, a scalable software platform for the structured organization and management of R&D activities. Companies use Clusterix to efficiently manage innovation projects, digitize internal processes, and make their R&D activities transparent and scalable.
